GlassScriptPhysician profile
Simon Finger
NPI 1548444904
$3,085.98
in general payments reported to CMS, 2019-2025
13 companies · $685 in 2025
The $685 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $88.06 · 2021: $163 · 2022: $640 · 2023: $572 · 2024: $757 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,013.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,601.41 | 2019-2025 | Mako, Aequalis Perform, Triathlon |
| Alon Medical Technology | $86.39 | 2019 | |
| Depuy Synthes Sales INC. | $70.53 | 2019-2022 | |
| Davol INC. | $70.34 | 2024-2025 | Channel Drain |
| Smith+Nephew, INC. | $64.01 | 2022 | |
| Sanofi-Aventis U.S. LLC | $51.71 | 2019-2020 | |
| Biom'Up France Sas | $46.39 | 2021 | |
| Convatec INC. | $21.07 | 2021 | |
| Bioventus LLC | $20.14 | 2020 | |
| Kci USA, INC. | $17.01 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.94 | 2024 | Exparel, Iovera, Zilretta |
| Vertex Pharmaceuticals Incorporated | $14.15 | 2025 | |
| Microport Orthopedics INC | $5.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Finger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.